Publications by authors named "Mary Bachinsky"

Claim this Profile
2
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic).
Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu, Claudia Ianos

J Child Adolesc Psychopharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study.
Robert L Findling, Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu

J Child Adolesc Psychopharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects.
Richat Abbas, Steve Riley, Sunil Nepal, Mary Bachinsky, Kimberly C Lee

Clin Pharmacol Drug Dev· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects.
Richat Abbas, Steve Riley, Robert R LaBadie, Mary Bachinsky, Phillip B Chappell

Clin Pharmacol Drug Dev· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Gary S Sachs, Douglas G Vanderburg, Onur N Karayal, Sheela Kolluri, Mary Bachinsky

J Clin Psychiatry· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.
Gary S Sachs, Douglas G Vanderburg, Suzanne Edman, Onur N Karayal, Sheela Kolluri, Mary Bachinsky

J Clin Psychiatry· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
Onur N Karayal, Paul Glue, Mary Bachinsky, Michelle Stewart, Phillip Chappell

J Psychiatr Pract· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis